The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis - PubMed (original) (raw)

The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis

Eun-Kyoung Yim et al. Cancer Res Treat. 2005 Dec.

Abstract

Cervical cancer is one of the leading world causes of cancer morbidity and mortality in woman, with more than 98% related to a human papillomavirus (HPV) infection origin. Infection with specific subtypes of HPV has been strongly implicated in cervical carcinogenesis. The identification and functional verification of host proteins associated with HPV E6 and E7 oncoproteins may provide useful information in understanding cervical carcinogenesis and the development of cervical cancer-specific markers. The advent of functional genomics and proteomics has provided hope of discovering novel biological markers for use in the screening, early diagnosis, prognostication and prediction of response to therapy. Herein, we review the studies where the profiles of host proteins associated with HPV E6 and E7 oncoproteins in cervical cancer were generated.

Keywords: Cervix neoplasms; E6; E7; Genomics; HPV; Proteomics.

PubMed Disclaimer

Figures

Fig. 1

HPV E6 and E7 binding to P53, with Rb interfering with the normal functions of the tumor suppressors.

Similar articles

• Role of proteomics in translational research in cervical cancer.
  Yim EK, Park JS. Yim EK, et al. Expert Rev Proteomics. 2006 Feb;3(1):21-36. doi: 10.1586/14789450.3.1.21. Expert Rev Proteomics. 2006. PMID: 16445348 Review.
• Bioinformatics analysis of HPV-68 E6 and E7 oncoproteins for designing a therapeutic epitope vaccine against HPV infection.
  Dong D, Zhu Y, Aili Z, Chen Z, Ding J. Dong D, et al. Infect Genet Evol. 2020 Jul;81:104266. doi: 10.1016/j.meegid.2020.104266. Epub 2020 Feb 27. Infect Genet Evol. 2020. PMID: 32114254
• Immunohistochemical Evaluation of E6/E7 HPV Oncoproteins Staining in Cervical Cancer.
  Stiasny A, Kuhn C, Mayr D, Alexiou C, Janko C, Wiest I, Jeschke U, Kost B. Stiasny A, et al. Anticancer Res. 2016 Jun;36(6):3195-8. Anticancer Res. 2016. PMID: 27272848
• Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
  Yugawa T, Kiyono T. Yugawa T, et al. Rev Med Virol. 2009 Mar;19(2):97-113. doi: 10.1002/rmv.605. Rev Med Virol. 2009. PMID: 19156753 Review.
• Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
  Santin AD, Hermonat PL, Ravaggi A, Chiriva-Internati M, Pecorelli S, Parham GP. Santin AD, et al. Cancer. 1998 Dec 1;83(11):2346-52. doi: 10.1002/(sici)1097-0142(19981201)83:11<2346::aid-cncr14>3.0.co;2-g. Cancer. 1998. PMID: 9840534

Cited by

• Cellular angiofibroma in women: a review of the literature.
  Mandato VD, Santagni S, Cavazza A, Aguzzoli L, Abrate M, La Sala GB. Mandato VD, et al. Diagn Pathol. 2015 Jul 19;10:114. doi: 10.1186/s13000-015-0361-6. Diagn Pathol. 2015. PMID: 26187500 Free PMC article. Review.
• Detection of High-Grade Cervical Intraepithelial Neoplasia by Electrical Impedance Spectroscopy in Women Diagnosed with Low-Grade Cervical Intraepithelial Neoplasia in Cytology.
  Panagakis G, Papapanagiotou IK, Theofanakis C, Tsetsa P, Kontogeorgi A, Thomakos N, Rodolakis A, Haidopoulos D. Panagakis G, et al. Life (Basel). 2023 Oct 31;13(11):2139. doi: 10.3390/life13112139. Life (Basel). 2023. PMID: 38004279 Free PMC article.
• A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
  Mariano VS, Lorenzi AT, Scapulatempo-Neto C, Stein MD, Resende JC, Antoniazzi M, Villa LL, Levi JE, Longatto-Filho A, Fregnani JH. Mariano VS, et al. PLoS One. 2016 Oct 20;11(10):e0164892. doi: 10.1371/journal.pone.0164892. eCollection 2016. PLoS One. 2016. PMID: 27764154 Free PMC article.
• Biological and clinical relevance of correlated expression levels of coding and long noncoding RNAs in HPV16 positive cervical cancers.
  Ghosh A, Sinha A, Ghosh A, Roy S, Mallick S, Kumar V, Mathai S, Bhaumik J, Mukhopadhyay A, Sen S, Chandra A, Maitra A, Biswas NK, Majumder PP, Sengupta S. Ghosh A, et al. Hum Genomics. 2024 Aug 29;18(1):91. doi: 10.1186/s40246-024-00660-2. Hum Genomics. 2024. PMID: 39210444 Free PMC article.
• Therapeutic DNA Vaccines against HPV-Related Malignancies: Promising Leads from Clinical Trials.
  Tang J, Li M, Zhao C, Shen D, Liu L, Zhang X, Wei L. Tang J, et al. Viruses. 2022 Jan 25;14(2):239. doi: 10.3390/v14020239. Viruses. 2022. PMID: 35215833 Free PMC article. Review.

References

1. 1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–19. - PubMed
2. 1. Lipari F, McGibbon GA, Wardrop E, Cordingley MG. Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry. 2001;40:1196–1204. - PubMed
3. 1. Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell. 1991;67:547–556. - PubMed
4. 1. Jones DL, Munger K. Interactions of the human papillomavirus E7 protein with cell cycle regulators. Semin Cancer Biol. 1996;7:327–337. - PubMed
5. 1. Lipinski MM, Jacks T. The retinoblastoma gene family in differentiation and development. Oncogene. 1999;18:7873–7882. - PubMed

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • M2PI
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database